JPMorgan Upgrades Vifor Pharma AG (VIFN:SW) (GNHAY) to Neutral

April 8, 2021 3:52 AM EDT
Get Alerts VIFN:SW Hot Sheet
Price: $0.00 --0%

Rating Summary:
    0 Buy, 0 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 7 | Down: 7 | New: 42
Trade Now! 
Join SI Premium – FREE

JPMorgan analyst James Gordon upgraded Vifor Pharma AG (VIFN:SW) (OTC: GNHAY) from Underweight to Neutral with a price target of CHF130.00 (from CHF120.00).


You May Also Be Interested In





Related Categories

Analyst PT Change, Intl Ratings, Upgrades